Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 1998

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

monoclonal antibody muJ591

Trial Locations (1)

10021

New York Presbyterian Hospital - Cornell Campus, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER